Massachusetts Financial Services CO Nevro Corp Transaction History

Massachusetts Financial Services CO

$320 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$40.85 - $77.67 $9.96 Million - $18.9 Million	-243,887 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$59.95 - $92.06 $4.51 Million - $6.93 Million	-75,306 Reduced 23.59%	243,887 $17.6 Million
Q4 2021 Feb 10, 2022	BUY	$81.07 - $121.29 $3.21 Million - $4.8 Million	39,542 Added 14.14%	319,193 $25.9 Million
Q3 2021 Nov 10, 2021	BUY	$101.99 - $166.36 $6.23 Million - $10.2 Million	61,085 Added 27.95%	279,651 $32.5 Million
Q2 2021 Aug 13, 2021	BUY	$141.6 - $179.06 $11.7 Million - $14.8 Million	82,422 Added 60.54%	218,566 $36.2 Million
Q1 2021 May 13, 2021	SELL	$132.81 - $182.18 $431,366 - $591,720	-3,248 Reduced 2.33%	136,144 $19 Million
Q4 2020 Feb 12, 2021	BUY	$138.17 - $184.34 $355,373 - $474,122	2,572 Added 1.88%	139,392 $24.1 Million
Q3 2020 Nov 12, 2020	SELL	$114.09 - $145.51 $383,342 - $488,913	-3,360 Reduced 2.4%	136,820 $19.1 Million
Q2 2020 Aug 11, 2020	SELL	$89.45 - $129.85 $736,889 - $1.07 Million	-8,238 Reduced 5.55%	140,180 $16.7 Million
Q1 2020 May 14, 2020	SELL	$70.23 - $144.31 $172,625 - $354,713	-2,458 Reduced 1.63%	148,418 $14.8 Million
Q4 2019 Feb 13, 2020	SELL	$76.41 - $117.54 $2.24 Million - $3.45 Million	-29,353 Reduced 16.29%	150,876 $17.7 Million
Q3 2019 Nov 05, 2019	SELL	$61.52 - $91.1 $2.09 Million - $3.1 Million	-34,025 Reduced 15.88%	180,229 $15.5 Million
Q2 2019 Aug 14, 2019	BUY	$58.04 - $66.99 $2.01 Million - $2.32 Million	34,625 Added 19.28%	214,254 $13.9 Million
Q1 2019 May 13, 2019	BUY	$35.52 - $62.62 $6.38 Million - $11.2 Million	179,629 New	179,629 $11.2 Million
Q4 2018 Feb 08, 2019	SELL	$35.43 - $56.29 $9.82 Million - $15.6 Million	-277,306 Closed	0 $0
Q3 2018 Oct 25, 2018	SELL	$44.22 - $75.47 $791,891 - $1.35 Million	-17,908 Reduced 6.07%	277,306 $15.8 Million
Q2 2018 Jul 30, 2018	SELL	$72.38 - $92.5 $279,676 - $357,420	-3,864 Reduced 1.29%	295,214 $23.6 Million
Q1 2018 May 04, 2018	BUY	$69.46 - $88.57 $185,527 - $236,570	2,671 Added 0.9%	299,078 $25.9 Million
Q4 2017 Feb 14, 2018	BUY	$65.94 - $93.31 $8.06 Million - $11.4 Million	122,299 Added 70.24%	296,407 $20.5 Million
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $85,883 - $96,726	1,062 Added 0.61%	174,108 $15.8 Million
Q2 2017 Aug 14, 2017	BUY	N/A	173,046	173,046 $12.9 Million

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

Arrow Mark Colorado Holdings LLC Denver, CO

4.39M
Shares

$16.6 Million
0.35% of portfolio
Armistice Capital, LLC New York, NY

3.73M
Shares

$14.1 Million
0.35% of portfolio
Black Rock Inc. New York, NY

3.6M
Shares

$13.6 Million
0.0% of portfolio
Glenn Welling Engaged Capital LLC | Newport Beach, Ca

2.44M
Shares

$9.21 Million
2.49% of portfolio
Vanguard Group Inc Valley Forge, PA

2.1M
Shares

$7.9 Million
0.0% of portfolio

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account